Breast cancer and spironolactone: an observational postmarketing study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer and spironolactone: an observational postmarketing study
Authors
Keywords
Spironolactone, Breast cancer, Antialdosterone
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-16
DOI
10.1007/s00228-019-02740-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Case–non-case studies: Principle, methods, bias and interpretation
- (2019) Jean-Luc Faillie THERAPIE
- What is pharmacoepidemiology? Definition, methods, interest and clinical applications
- (2018) Jean-Louis Montastruc et al. THERAPIE
- Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
- (2018) Devin Abrahami et al. BMJ-British Medical Journal
- False-positive results in pharmacoepidemiology and pharmacovigilance
- (2017) Julien Bezin et al. THERAPIE
- Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
- (2016) Isla S. Mackenzie et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Male breast cancer is not congruent with the female disease
- (2016) Ian S. Fentiman CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study
- (2016) Inés Gómez-Acebo et al. PLoS One
- French pharmacovigilance: Missions, organization and perspectives
- (2016) Thierry Vial THERAPIE
- Spironolactone use and the risk of breast and gynecologic cancers
- (2013) Robert J. Biggar et al. Cancer Epidemiology
- vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues
- (2013) Tomas Bergvall et al. DRUG SAFETY
- Effect of Competition Bias in Safety Signal Generation
- (2012) Antoine Pariente et al. DRUG SAFETY
- Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study
- (2012) I. S. Mackenzie et al. BMJ-British Medical Journal
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
- (2011) Jean-Louis Montastruc et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Breast Cancer Before Age 40 Years
- (2009) Carey K. Anders et al. SEMINARS IN ONCOLOGY
- The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database
- (2008) A. Bate et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started